Conventional and molecular cytogenetic diagnostic methods in stem cell research:: A concise review

被引:33
作者
Catalina, Purificacion
Cobo, Fernando
Cortes, Jose L.
Nieto, Ana I.
Cabrera, Carmen
Montes, Rosa
Concha, Angel
Menendez, Pablo
机构
[1] Inst Invest Biomed, Andalusian Stem Cell Bank, Granada 18014, Spain
[2] Hosp Virgen Nieves, Serv Anat Patol, Granada, Spain
关键词
stem cell research; cytogenetics; fluorescence in situ hybridization; karyotyping; comparative genomic hybridization; spectral karyotyping;
D O I
10.1016/j.cellbi.2007.03.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Regenerative medicine and cell therapy are emerging clinical disciplines in the field of stem cell biology. The most important sources for cell transplantation are human embryonic and adult stem cells. The future use of these human stein cell lines in humans requires a guarantee of exhaustive control with respect to quality control, safety and traceability. Genetic instability and chromosomal abnormalities represent a potential weakness in basic studies and future therapeutic applications based on these stem cell lines, and may explain, at least in part, their usual tumourigenic properties. So, the introduction of the cytogenetic programme in the determination of the chromosomal stability is a key point in the establishment of the stem cell lines. The aim of this review is to provide readers with an up-to-date overview of all the cytogenetic techniques, both conventional methods and molecular fluorescence methods, to be used in a stem cell bank or other stem cell research centres. Thus, it is crucial to optimize and validate their use in the determination of the chromosomal stability of these stem cell lines, and assess the advantages and limitations of these cutting-edge cytogenetic technologies. (C) 2007 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 42 条
[1]   Advances in the detection of chromosomal aberrations using spectral karyotyping [J].
Bayani, J ;
Squire, JA .
CLINICAL GENETICS, 2001, 59 (02) :65-73
[2]  
BRENNER M, 2003, FLUORESCENCE SITU HY, P22
[3]   Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001 [J].
Brimble, SN ;
Zeng, XM ;
Weiler, DA ;
Luo, YQ ;
Liu, Y ;
Lyons, IG ;
Freed, WJ ;
Robins, AJ ;
Rao, MS ;
Schulz, TC .
STEM CELLS AND DEVELOPMENT, 2004, 13 (06) :585-597
[4]   Signalling, cell cycle and pluripotency in embryonic stem cells [J].
Burdon, T ;
Smith, A ;
Savatier, P .
TRENDS IN CELL BIOLOGY, 2002, 12 (09) :432-438
[5]   Karyotype of human ES cells during extended culture [J].
Buzzard, JJ ;
Gough, NM ;
Crook, JM ;
Colman, A .
NATURE BIOTECHNOLOGY, 2004, 22 (04) :381-382
[6]   Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture [J].
Caisander, G ;
Park, H ;
Frej, K ;
Lindqvist, J ;
Bergh, C ;
Lundin, K ;
Hanson, C .
CHROMOSOME RESEARCH, 2006, 14 (02) :131-137
[7]   Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma [J].
Clark, AT ;
Rodriguez, RT ;
Bodnar, MS ;
Abeyta, MJ ;
Cedars, MI ;
Turek, PJ ;
Firpo, MT ;
Pera, RAR .
STEM CELLS, 2004, 22 (02) :169-179
[8]   Microbiological control in stem cell banks:: approaches to standardisation [J].
Cobo, F ;
Stacey, GN ;
Hunt, C ;
Cabrera, C ;
Nieto, A ;
Montes, R ;
Cortés, JL ;
Catalina, P ;
Barnie, A ;
Concha, A .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2005, 68 (04) :456-466
[9]  
Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330
[10]   Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells [J].
Draper, JS ;
Smith, K ;
Gokhale, P ;
Moore, HD ;
Maltby, E ;
Johnson, J ;
Meisner, L ;
Zwaka, TP ;
Thomson, JA ;
Andrews, PW .
NATURE BIOTECHNOLOGY, 2004, 22 (01) :53-54